PayZen: Cost Concerns Push 2 in 5 Patients to AI Over Doctors

What happened

Healthcare payments company PayZen has published new research finding that cost concerns are pushing a significant share of patients toward artificial intelligence tools instead of in-person medical consultations. According to the report, more than two in five patients say they would turn to AI rather than see a doctor when faced with the expense of a traditional visit.

The finding points to a shift in how patients weigh the cost, speed and accessibility of care, with affordability emerging as a decisive factor in whether they seek a human clinician or rely on an AI-based alternative.

Why it matters

For healthcare providers, payers and digital health platforms, this signals that financial friction is now a primary driver of channel choice — not just convenience or triage speed. When cost becomes the deciding factor, AI tools are no longer positioned purely as a supplement to care; for a meaningful portion of patients, they are becoming a substitute.

This has direct implications for how health systems design their digital front doors, pricing transparency and financing options. Organisations that fail to address the cost barrier risk pushing patients toward unverified or lower-quality AI substitutes, with potential consequences for both patient outcomes and trust in the broader care journey.

The Renascence take

This is a textbook case of behavioral economics shaping a service decision: when the perceived cost of the "default" option rises, people don't necessarily abandon the need — they route around the barrier. The real story here isn't that AI is replacing doctors; it's that affordability friction is strong enough to override trust in human expertise for a large share of patients.

Most healthcare leaders will read this as an AI adoption story. It isn't — it's a pricing and access story wearing an AI costume. The moment paying for care feels like a loss, patients will choose whatever reduces that loss, even if it means lower-quality guidance. Providers that want to keep patients inside a trusted care pathway need to make the cost of seeing a human transparent and manageable at the point of decision — not after the appointment is booked.